COMPANY

Aruna Bio, Inc.

HQ: Athens, GA source · arunabio.com ↗ · Southeast

Also known as Aruna Bio · 2 sources

Location: Athens, GA · source · Oct 15, 2026

Profile checked Oct 10, 2026

Keywords: Acute Ischemic Stroke

Timeline

2026-10 Trial start 1: A Phase 1b Study to Assess the Safety and Tolerability of AB126 Neural Exosomes in Patients With Moderate to Severe Acute Ischemic Stroke source ↗
Aug 7, 2025 Grant Government grant — SBIR: $399,997 (annual award, as published), announced Aug 7, 2025. Agency: NIH/NIDA. Source: government award database. source ↗

2028-10 (ESTIMATED) · 1 · A Phase 1b Study to Assess the Safety and Tolerability of AB126 Neural Exosomes in Patients With Moderate to Severe Acute Ischemic Stroke · NCT07813130

Estimated primary completion per ClinicalTrials.gov. Dates move.

Last 2 years.

Aug 7, 2025 Government grant — SBIR: $399,997 (annual award, as published), announced Aug 7, 2025. Agency: NIH/NIDA. Source: government award database. source ↗

Record	Title	Phase	Status	Start	Primary completion
NCT07813130	A Phase 1b Study to Assess the Safety and Tolerability of AB126 Neural Exosomes in Patients With Moderate to Severe Acute Ischemic Stroke	1	Not yet recruiting	2026-10	2028-10 (estimated)